Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone: Update of a Randomized Clinical Trial

Jesse Ory; Parris Diaz; Marco Jose Rivero; Raul I. Clavijo; Nannan Thirumavalavan; Ruben Blachman-Braun; Justin Loloi; Ari Bernstein; Ranjith Ramasamy

doi:10.1016/j.euf.2022.09.001

Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone: Update of a Randomized Clinical Trial

Jesse Ory, Parris Diaz, Marco Jose Rivero, Raul I. Clavijo, Nannan Thirumavalavan, Ruben Blachman-Braun, Justin Loloi, Ari Bernstein, Ranjith Ramasamy

Medicine

Producción científica: Contribución a una revista › Comentario/debate › revisión exhaustiva

5 Citas (Scopus)

Idioma original	English
Publicación	European Urology Focus
DOI	https://doi.org/10.1016/j.euf.2022.09.001
Estado	Accepted/In press - 2022

Nota bibliográfica

Funding Information:
Conflicts of interest : Ranjith Ramasamy is a consultant for Acerus Pharmaceuticals, Boston Scientific, Endo Pharmaceuticals, and Coloplast; has received grants from Acerus Pharmaceuticals, Boston Scientific, Endo Pharmaceuticals, Coloplast, Empower Pharmacy, and Olympus; is an advisory board member for Hims, Inc.; and has received National Institutes of Health funding (1R01DK130991-01). Jesse Ory is a consultant for and has received grants from Acerus Pharmaceuticals. The remaining authors have nothing to disclose.

ASJC Scopus Subject Areas

Urology

PubMed: MeSH publication types

Journal Article

Acceder al documento

10.1016/j.euf.2022.09.001

Otros archivos y enlaces

Citar esto

Ory, J., Diaz, P., Rivero, M. J., Clavijo, R. I., Thirumavalavan, N., Blachman-Braun, R., Loloi, J., Bernstein, A., & Ramasamy, R. (Aceptado/En prensa). Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone: Update of a Randomized Clinical Trial. European Urology Focus. https://doi.org/10.1016/j.euf.2022.09.001

@article{48c7eaa7db144ba394e5daa865359d54,

title = "Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone: Update of a Randomized Clinical Trial",

author = "Jesse Ory and Parris Diaz and Rivero, {Marco Jose} and Clavijo, {Raul I.} and Nannan Thirumavalavan and Ruben Blachman-Braun and Justin Loloi and Ari Bernstein and Ranjith Ramasamy",

note = "Funding Information: Conflicts of interest : Ranjith Ramasamy is a consultant for Acerus Pharmaceuticals, Boston Scientific, Endo Pharmaceuticals, and Coloplast; has received grants from Acerus Pharmaceuticals, Boston Scientific, Endo Pharmaceuticals, Coloplast, Empower Pharmacy, and Olympus; is an advisory board member for Hims, Inc.; and has received National Institutes of Health funding (1R01DK130991-01). Jesse Ory is a consultant for and has received grants from Acerus Pharmaceuticals. The remaining authors have nothing to disclose. ",

year = "2022",

doi = "10.1016/j.euf.2022.09.001",

language = "English",

journal = "European Urology Focus",

issn = "2405-4569",

publisher = "Elsevier BV",

}

TY - JOUR

T1 - Comparing Rates of Polycythemia in Hypogonadal Men Using Nasal Testosterone Gel Versus Intramuscular Testosterone

T2 - Update of a Randomized Clinical Trial

AU - Ory, Jesse

AU - Diaz, Parris

AU - Rivero, Marco Jose

AU - Clavijo, Raul I.

AU - Thirumavalavan, Nannan

AU - Blachman-Braun, Ruben

AU - Loloi, Justin

AU - Bernstein, Ari

AU - Ramasamy, Ranjith

N1 - Funding Information: Conflicts of interest : Ranjith Ramasamy is a consultant for Acerus Pharmaceuticals, Boston Scientific, Endo Pharmaceuticals, and Coloplast; has received grants from Acerus Pharmaceuticals, Boston Scientific, Endo Pharmaceuticals, Coloplast, Empower Pharmacy, and Olympus; is an advisory board member for Hims, Inc.; and has received National Institutes of Health funding (1R01DK130991-01). Jesse Ory is a consultant for and has received grants from Acerus Pharmaceuticals. The remaining authors have nothing to disclose.

PY - 2022

Y1 - 2022

UR - http://www.scopus.com/inward/record.url?scp=85138054333&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85138054333&partnerID=8YFLogxK

U2 - 10.1016/j.euf.2022.09.001

DO - 10.1016/j.euf.2022.09.001

M3 - Comment/debate

C2 - 36109330

AN - SCOPUS:85138054333

SN - 2405-4569

JO - European Urology Focus

JF - European Urology Focus

ER -